Ambolodto, Zain S.

HRN: 26-30-60  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2024
CEFTRIAXONE 1G (VIAL)
11/30/2024
11/30/2024
IVT
285mg
Q12
Pneumonia
Waiting Final Action 
12/02/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/02/2024
12/09/2024
INTRAVENOUS
75 Mg
Every 24 Hours
PCAP-C 9
Waiting Final Action 
12/04/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
12/04/2024
12/11/2024
ORAL
0.5 Ml
Every 6 Hourd
Oral Candidiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: